Literature DB >> 17186115

Ganciclovir-resistant, cytomegalic interstitial lung disease in a patient with systemic lupus erythematosus.

Eduardo Finger1, Helio Romaldini, David Salomão Lewi, Morton Aaron Scheinberg.   

Abstract

A patient with systemic lupus erythematosus developed interstitial lung disease initially felt to be a manifestation of the disease but that, on further workup, proved to be a manifestation of cytomegalic disease resistant to ganciclovir. Treatment with foscarnet was associated with prompt improvement.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17186115     DOI： 10.1007/s10067-006-0500-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  18 in total

Review 1.  Cytomegalovirus pneumonia.

Authors:  N Salomon; D C Perlman
Journal:  Semin Respir Infect       Date:  1999-12

2.  Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.

Authors:  G Boivin; N Goyette; C Gilbert; A Humar; E Covington
Journal:  Transpl Infect Dis       Date:  2005 Sep-Dec       Impact factor: 2.228

Review 3.  Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.

Authors:  Nina Singh
Journal:  Clin Infect Dis       Date:  2005-02-04       Impact factor: 9.079

4.  [Cytomegalic inclusion disease in a patient with systemic lupus].

Authors:  J Sánchez-Román; J M Varela-Aguilar; I Fraile; J Andreu-Alvarez; J Fernández Alonso
Journal:  Rev Clin Esp       Date:  1991-01       Impact factor: 1.556

5.  Human cytomegalovirus in patients with systemic lupus erythematosus.

Authors:  Antoni Hrycek; Dariusz Kuśmierz; Urszula Mazurek; Tadeusz Wilczok
Journal:  Autoimmunity       Date:  2005-11       Impact factor: 2.815

Review 6.  Management of CMV infection and disease in transplant patients. 27-29 February 2004.

Authors:  Raymund R Razonable; Vincent C Emery
Journal:  Herpes       Date:  2004-12

Review 7.  Interstitial lung disease in systemic lupus erythematosus.

Authors:  G S Cheema; F P Quismorio
Journal:  Curr Opin Pulm Med       Date:  2000-09       Impact factor: 3.155

Review 8.  Is combination antiviral therapy for CMV superior to monotherapy?

Authors:  W Lawrence Drew
Journal:  J Clin Virol       Date:  2006-01-18       Impact factor: 3.168

9.  Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease.

Authors:  Sabiha Shahnaz; Mamta T Choksi; Irene J Tan
Journal:  Mayo Clin Proc       Date:  2003-11       Impact factor: 7.616

Review 10.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.